Infliximab treatment in patients with interstitial lung disease and rheumatoid arthritis Source: Eur Respir J 2002; 20: Suppl. 38, 587s Year: 2002
Infliximab therapy in interstitial lung disease associated with rheumatoid arthritis Source: Annual Congress 2004 - Fibrosing lung diseases Year: 2004
Rituximab improves interstitial lung disease in rheumatoid arthritis patients Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017
Methotrexate and rheumatoid arthritis associated interstitial lung disease Source: Eur Respir J, 57 (2) 2000337; 10.1183/13993003.00337-2020 Year: 2021
Interstitial lung disease in patients with rheumatoid arthritis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008
Pulmonary involvement in patients with rheumatoid arthritis Source: Eur Respir J 2006; 28: Suppl. 50, 381s Year: 2006
Pulmonary manifestations in patients with rheumatoid arthritis Source: Eur Respir J 2006; 28: Suppl. 50, 100s Year: 2006
RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients Source: Eur Respir J 2014; 44: 1082-1085 Year: 2014
Pulmonary disease associated with rheumatoid arthritis Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021
Pulmonary non-Hodgkin‘s lymphoma developed during long-term methotrexate therapy for rheumatoid arthritis Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009
Pulmonary involvement in rheumatoid arthritis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008
Pulmonary involvement in rheumatoid arthritis Source: Eur Respir Monogr 2019; 86: 44-67 Year: 2019
Effect of tocilizumab on interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment Year: 2020
Pulmonary nodular lesions in rheumatoid arthritis patients Source: Eur Respir J 2002; 20: Suppl. 38, 60s Year: 2002
The effect of Rituximab treatment on progression of Rheumatoid arthritis-associated interstitial lung disease Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management Year: 2018
Mortality and clinical features in rheumatoid arthritis and interstitial lung disease Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017
Cavitary nodules in rheumatoid arthritis patients and their prognosis Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018
Pulmonary involvement in spondilarthropathies and rheumatoid polyarthritis Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002
Cytokine gene polymorphisms in fibrosing alveolitis in rheumatoid arthritis and idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 1s Year: 2001
Predicting outcomes in rheumatoid arthritis related interstitial lung disease Source: Eur Respir J, 53 (1) 1800869; 10.1183/13993003.00869-2018 Year: 2019